bf/NYSE:CAH_icon.jpeg

COM:CARDINALHEALTH

Cardinal Health, Inc.

  • Stock

Last Close

120.34

21/11 21:00

Market Cap

23.28B

Beta: -

Volume Today

2.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
8.32B
-
8.74B
5.04%
9.91B
13.44%
10.96B
10.54%
11.80B
7.72%
12.56B
6.44%
13.01B
3.54%
13.90B
6.81%
15.12B
8.77%
15.79B
4.45%
15.45B
2.15%
average payables
12.22B
-
13.26B
8.48%
15.84B
19.45%
17.61B
11.17%
18.79B
6.73%
20.61B
9.66%
21.45B
4.12%
22.54B
5.05%
25.41B
12.77%
28.47B
12.03%
30.79B
8.13%
average receivables
5.84B
-
5.95B
1.87%
6.96B
17.01%
7.73B
10.95%
7.92B
2.56%
8.12B
2.52%
8.36B
2.86%
8.68B
3.92%
9.83B
13.23%
10.95B
11.40%
11.71B
6.95%
book value per share
18.77
-
18.84
0.38%
20.04
6.37%
21.48
7.15%
19.36
9.86%
21.10
9.00%
6.12
71.01%
6.14
0.45%
-2.53
141.19%
-10.92
331.67%
-13.11
20.06%
capex per share
-0.73
-
-0.90
23.75%
-1.42
57.37%
-1.22
14.15%
-1.23
0.49%
-1.09
10.88%
-1.28
17.06%
-1.37
7.03%
-1.39
1.26%
-1.84
32.86%
2.09
213.17%
capex to depreciation
-0.54
-
-0.67
22.62%
-0.73
9.06%
-0.54
25.60%
-0.37
31.06%
-0.33
11.85%
-0.41
25.22%
-0.51
24.38%
-0.56
9.47%
-0.70
24.29%
0.72
203.54%
capex to operating cash flow
-0.10
-
-0.12
19.72%
-0.16
32.51%
-0.33
108.84%
-0.14
57.56%
-0.12
13.14%
-0.19
58.78%
-0.16
13.93%
-0.12
24.73%
-0.17
36.68%
0.14
180.17%
capex to revenue
-0.00
-
-0.00
7.03%
-0.00
30.75%
-0.00
22.17%
-0.00
5.73%
-0.00
19.70%
-0.00
8.81%
-0.00
0.40%
-0.00
13.33%
-0.00
9.95%
0.00
196.02%
cash per share
8.40
-
13.90
65.48%
7.20
48.18%
21.70
201.19%
5.63
74.04%
8.44
49.78%
9.46
12.10%
11.67
23.37%
16.91
44.90%
15.49
8.38%
20.95
35.25%
days of inventory on hand
35.11
-
34.72
1.11%
33.69
2.98%
33.42
0.81%
34.66
3.70%
33.74
2.64%
32.98
2.25%
34.21
3.73%
32.65
4.58%
29.37
10.05%
24.88
15.27%
days payables outstanding
51.61
-
54.17
4.96%
54.93
1.40%
52.95
3.60%
55.41
4.64%
56.67
2.28%
53.42
5.75%
55.56
4.02%
56.64
1.94%
54.92
3.03%
52.83
3.81%
days sales outstanding
21.56
-
23.22
7.71%
22.24
4.24%
22.60
1.63%
20.81
7.92%
21.19
1.81%
19.72
6.90%
20.45
3.68%
21.25
3.93%
20.20
4.98%
19.45
3.72%
debt to assets
0.15
-
0.18
19.42%
0.16
10.91%
0.26
59.64%
0.23
12.95%
0.20
13.10%
0.17
15.23%
0.14
15.59%
0.12
13.65%
0.11
10.61%
0.11
4.23%
debt to equity
0.62
-
0.88
41.47%
0.85
3.73%
1.53
80.67%
1.49
2.58%
1.27
14.71%
3.78
197.99%
3.48
8.06%
-7.53
316.58%
-1.65
78.10%
-1.58
3.89%
dividend yield
0.02
-
0.02
6.69%
0.02
21.18%
0.02
16.38%
0.04
62.73%
0.04
6.38%
0.04
7.99%
0.03
7.63%
0.04
11.52%
0.02
44.51%
0.02
2.05%
earnings yield
0.05
-
0.04
12.28%
0.06
27.87%
0.05
6.79%
0.02
67.88%
0.10
470.33%
-0.24
352.81%
0.04
115.18%
-0.06
274.37%
0.01
116.55%
0.04
236.41%
enterprise value
24.49B
-
28.65B
17.00%
28.69B
0.16%
28.22B
1.66%
22.53B
20.14%
19.77B
12.27%
19.30B
2.39%
19.50B
1.06%
15.18B
22.14%
25.34B
66.92%
23.91B
5.65%
enterprise value over ebitda
10.14
-
10.81
6.66%
9.34
13.64%
9.52
1.93%
7.81
18.01%
7.27
6.82%
7.18
1.23%
7.43
3.44%
6.49
12.69%
10.28
58.39%
19.24
87.19%
ev to operating cash flow
9.70
-
11.28
16.26%
9.66
14.37%
23.83
146.77%
8.14
65.84%
7.26
10.79%
9.84
35.56%
8.03
18.46%
4.86
39.43%
8.93
83.56%
6.36
28.80%
ev to sales
0.27
-
0.28
3.93%
0.24
15.51%
0.22
8.04%
0.16
24.13%
0.14
17.53%
0.13
7.11%
0.12
4.88%
0.08
30.26%
0.12
47.67%
0.11
14.72%
free cash flow per share
6.67
-
6.75
1.13%
7.66
13.59%
2.51
67.19%
7.62
202.94%
7.98
4.77%
5.41
32.21%
6.95
28.45%
9.80
41.08%
9.03
7.84%
13.27
46.87%
free cash flow yield
0.10
-
0.08
17.11%
0.10
21.80%
0.03
67.16%
0.16
383.42%
0.17
7.57%
0.10
38.22%
0.12
17.43%
0.19
54.09%
0.10
49.06%
0.14
42.08%
graham net net
-25.22
-
-29.43
16.72%
-43.83
48.92%
-46.43
5.92%
-64.30
38.48%
-64.52
0.34%
-79.88
23.82%
-86.05
7.72%
-86.48
0.50%
-98.65
14.07%
-108.81
10.31%
graham number
38.00
-
39.39
3.65%
44.36
12.62%
44.31
0.12%
18.87
57.40%
46.44
146.07%
41.65
10.33%
17.01
59.16%
13.79
18.91%
15.68
13.68%
32.03
104.33%
income quality
2.17
-
2.10
3.43%
2.08
0.93%
0.91
55.93%
10.69
1,068.02%
1.99
81.34%
-0.53
126.61%
3.97
847.82%
-3.35
184.40%
10.84
423.48%
4.41
59.30%
intangibles to total assets
0.23
-
0.20
11.45%
0.28
38.36%
0.23
16.91%
0.31
33.36%
0.29
5.83%
0.28
4.05%
0.23
17.90%
0.17
23.43%
0.14
19.44%
0.14
2.06%
interest coverage
14.17
-
15.33
8.14%
13.81
9.86%
10.55
23.65%
0.38
96.37%
7.01
1,729.55%
7.45
6.32%
10.23
37.29%
11.06
8.14%
7.82
29.32%
24.37
211.78%
interest debt per share
12.04
-
16.97
40.94%
17.48
3.04%
33.43
91.19%
29.85
10.71%
27.75
7.02%
23.94
13.75%
21.97
8.20%
19.58
10.87%
18.37
6.21%
20.99
14.29%
inventory turnover
10.39
-
10.51
1.12%
10.83
3.07%
10.92
0.81%
10.53
3.57%
10.82
2.71%
11.07
2.30%
10.67
3.60%
11.18
4.80%
12.43
11.17%
14.67
18.02%
invested capital
0.62
-
0.88
41.47%
0.85
3.73%
1.53
80.67%
1.49
2.58%
1.27
14.71%
3.78
197.99%
3.48
8.06%
-7.53
316.58%
-1.65
78.10%
8.22B
498,697,575,084.05%
market cap
23.38B
-
27.77B
18.79%
25.51B
8.15%
24.70B
3.17%
15.28B
38.12%
14.27B
6.65%
15.29B
7.17%
16.67B
9.02%
14.58B
12.52%
24.68B
69.25%
23.95B
2.96%
net current asset value
-1.69B
-
-2.13B
26.05%
-5.59B
162.18%
-4.94B
11.72%
-9.34B
89.09%
-8.89B
4.85%
-13.03B
46.68%
-11.61B
10.92%
-11.65B
0.33%
-12.44B
6.75%
-13.45B
8.16%
net debt to ebitda
0.46
-
0.33
27.86%
1.04
213.32%
1.19
14.49%
2.51
111.70%
2.02
19.42%
1.49
26.33%
1.08
27.68%
0.26
76.30%
0.27
4.41%
-0.03
112.36%
net income per share
3.42
-
3.66
7.03%
4.36
19.24%
4.06
6.89%
0.82
79.87%
4.54
455.49%
-12.60
377.42%
2.09
116.60%
-3.34
259.64%
1
129.94%
3.48
247.76%
operating cash flow per share
7.40
-
7.65
3.36%
9.09
18.76%
3.74
58.89%
8.84
136.77%
9.07
2.60%
6.69
26.27%
8.32
24.35%
11.19
34.52%
10.88
2.79%
15.36
41.17%
payables turnover
7.07
-
6.74
4.72%
6.65
1.38%
6.89
3.73%
6.59
4.43%
6.44
2.23%
6.83
6.10%
6.57
3.86%
6.44
1.90%
6.65
3.12%
6.91
3.96%
receivables turnover
16.93
-
15.72
7.16%
16.41
4.43%
16.15
1.61%
17.54
8.60%
17.23
1.78%
18.50
7.42%
17.85
3.55%
17.17
3.78%
18.07
5.24%
18.77
3.87%
research and ddevelopement to revenue
return on tangible assets
0.06
-
0.05
12.91%
0.06
14.73%
0.04
27.87%
0.01
77.84%
0.05
406.25%
-0.13
367.86%
0.02
114.20%
-0.03
244.58%
0.01
127.19%
0.02
215.17%
revenue per share
267.11
-
308.83
15.62%
371.70
20.36%
410.02
10.31%
437.09
6.60%
485.11
10.99%
521.92
7.59%
556.39
6.61%
650.05
16.83%
785.49
20.83%
925.82
17.87%
roe
0.18
-
0.19
6.62%
0.22
12.11%
0.19
13.11%
0.04
77.67%
0.22
409.63%
-2.06
1,057.08%
0.34
116.53%
1.32
287.61%
-0.09
106.93%
-0.27
189.66%
roic
0.09
-
0.08
12.78%
0.09
15.53%
0.05
40.16%
-0.01
111.42%
0.07
1,280.46%
0.11
54.68%
0.26
130.01%
0.21
17.92%
0.16
24.50%
0.47
191.14%
sales general and administrative to revenue
0.03
-
0.03
4.94%
0.03
5.02%
0.03
3.23%
0.03
15.67%
shareholders equity per share
18.77
-
18.84
0.38%
20.04
6.37%
21.48
7.15%
19.36
9.86%
21.10
9.00%
6.12
71.01%
6.14
0.45%
-2.53
141.19%
-10.92
331.67%
-13.11
20.06%
stock based compensation to revenue
0.00
-
0.00
1.79%
0.00
14.88%
0.00
19.12%
0.00
15.88%
0.00
9.31%
0.00
4.45%
0.00
6.92%
0.00
18.47%
0.00
4.85%
0.00
13.92%
tangible asset value
531M
-
238M
55.18%
-2.85B
1,299.58%
-2.38B
16.67%
-6.17B
159.35%
-5.48B
11.22%
-9.48B
73.11%
-8.30B
12.47%
-8.34B
0.42%
-8.93B
7.16%
-9.66B
8.18%
tangible book value per share
1.56
-
0.72
53.96%
-8.73
1,317.92%
-7.50
14.04%
-19.71
162.67%
-18.26
7.37%
-32.37
77.25%
-28.42
12.18%
-29.87
5.10%
-34.22
14.55%
-39.44
15.25%
working capital
2.82B
-
4.51B
59.67%
2.25B
49.99%
7.12B
215.92%
1.66B
76.70%
1.64B
1.33%
2.33B
41.94%
3.42B
47.27%
2.38B
30.34%
127M
94.68%
-756M
695.28%

All numbers in (except ratios and percentages)